| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
118,610,000 |
| Market
Cap: |
23.41(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1974 - $0.1974 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oncocyte is a molecular diagnostics company focused on developing and commercializing proprietary laboratory-developed tests to serve unmet medical needs across the cancer care continuum. Co.'s DetermaRx™ is a predictive molecular test for early-stage adenocarcinoma of the lung. This test provides information that a physician can use to help identify early-stage, surgically resected patients with Stage I and IIA non-squamous non-small cell lung cancer who are at high-risk of recurrence and may benefit from chemotherapy. Co.'s portfolio includes a gene expression-based test called DetermaIO™, which is being developed to identify patients most likely to respond to immunotherapy drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
6,362,024 |
7,833,752 |
10,291,040 |
| Total Buy Value |
$0 |
$13,043,148 |
$17,285,083 |
$24,452,771 |
| Total People Bought |
0 |
3 |
4 |
5 |
| Total Buy Transactions |
0 |
10 |
16 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Patrick W |
10% Owner |
– – • |
2025-02-07 |
4 |
A |
$2.05 |
$790,919 |
I/I |
385,814 |
3,258,485 |
|
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-02-07 |
4 |
B |
$2.05 |
$2,209,080 |
I/I |
1,077,600 |
2,872,671 |
1.5 |
- |
|
| James Andrea S. |
Chief Financial Officer |
• – – |
2025-02-07 |
4 |
B |
$2.05 |
$200,000 |
D/D |
97,561 |
151,231 |
2.74 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2025-02-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
11,410,100 |
1.42 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2025-02-06 |
4 |
B |
$2.05 |
$10,589,675 |
D/D |
5,165,695 |
11,410,100 |
2.45 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-02-04 |
4 |
B |
$2.02 |
$51 |
I/I |
25 |
1,795,071 |
1.42 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-01-31 |
4 |
B |
$2.01 |
$1,789 |
I/I |
890 |
1,795,046 |
1.42 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-01-30 |
4 |
B |
$2.01 |
$639 |
I/I |
318 |
1,794,156 |
1.42 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-01-29 |
4 |
B |
$2.01 |
$7,799 |
I/I |
3,880 |
1,793,838 |
1.5 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-01-14 |
4 |
B |
$2.08 |
$22,323 |
I/I |
10,386 |
1,789,958 |
1.5 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2025-01-13 |
4 |
B |
$2.08 |
$11,792 |
I/I |
5,669 |
1,779,572 |
1.5 |
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2024-12-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,683,684 |
|
- |
|
| Smith Patrick W |
10% Owner |
– – • |
2024-12-26 |
4 |
B |
$2.13 |
$192,166 |
I/I |
90,219 |
1,773,903 |
1.5 |
- |
|
| Arno Andrew |
Director |
– • – |
2024-12-26 |
4 |
B |
$2.11 |
$26,350 |
D/D |
12,500 |
81,554 |
2.39 |
- |
|
| James Andrea S. |
Chief Financial Officer |
• – – |
2024-12-05 |
4 |
B |
$2.29 |
$45,800 |
D/D |
20,000 |
53,670 |
2.74 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-10-02 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
6,244,405 |
1.42 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-10-02 |
4 |
B |
$2.95 |
$3,877,619 |
D/D |
1,315,339 |
6,244,405 |
2.45 |
- |
|
| James Andrea S. |
Chief Financial Officer |
• – – |
2024-10-02 |
4 |
B |
$2.97 |
$100,000 |
D/D |
33,670 |
33,670 |
2.74 |
- |
|
| Arno Andrew |
Director |
– • – |
2024-04-11 |
4 |
B |
$2.95 |
$99,999 |
D/D |
33,898 |
69,054 |
2.39 |
-100% |
|
| Riggs Josh |
CEO and President |
• • – |
2024-04-11 |
4 |
B |
$2.95 |
$10,001 |
D/D |
3,390 |
3,505 |
2.81 |
-100% |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
4,929,066 |
1.42 |
-100% |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$2.92 |
$7,057,688 |
D/D |
2,420,000 |
4,929,066 |
2.45 |
-100% |
|
| Gutfreund John Peter |
Former Director |
– – – |
2023-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,085,047) |
0 |
|
- |
|
| Arno Andrew |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
703,133 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
489,111 |
|
- |
|
160 Records found
|
|
Page 1 of 7 |
|
|
